Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data
Analysis: GRAIL’s stock performance reflects a wave of optimism about its Galleri cancer-screening test and pending trial results. In late September it broke out to new highs, aided by momentum and positive
